Revisión web de lifescivc.com
LifeSciVC - Bruce Booth, partner at Atlas Venture, blogs on all facets of early stage biotech.LifeSciVC | Bruce Booth, partner at Atlas Venture, blogs on all facets of early stage biotech.
Generado el 27 Marzo 2026 06:27 AM
Resultados antiguos? ACTUALIZAR !
La puntuación es 54/100
Contenido SEO
Título
LifeSciVC - Bruce Booth, partner at Atlas Venture, blogs on all facets of early stage biotech.LifeSciVC | Bruce Booth, partner at Atlas Venture, blogs on all facets of early stage biotech.
Longitud : 188
Preferiblemente, tu título debería contener entre 10 y 70 caracteres (espacios incluidos). Usa esta herramienta gratuita para calcular la longitud del texto.
Descripción
Bruce Booth, partner at Atlas Venture, blogs on all facets of early stage biotech.
Longitud : 82
Genial, tu descripción meta contiene entre 70 y 160 caracteres.
Palabras Claves (Keywords)
Muy mal. No hemos encontrado palabras clave (meta keywords) en tu página. Usa este generador de meta tags gratuito para crear tus palabras clave.
Propiedades Meta Og
Bien. Tu página usa propiedades Og (etiquetas og).
| Propiedad | Contenido |
|---|---|
| locale | en_US |
| type | website |
| title | LifeSciVC |
| description | Bruce Booth, partner at Atlas Venture, blogs on all facets of early stage biotech. |
| url | https://lifescivc.com/ |
| site_name | LifeSciVC |
Titulos
| H1 | H2 | H3 | H4 | H5 | H6 |
| 2 | 40 | 7 | 0 | 0 | 0 |
- [H1] Process-Driven Cadence: Biotech IPOs Demystified
- [H1] Atlas Venture 2025 Year In Review
- [H2] Twenty Years In Early Stage Biotech VC (Part 3): BusinessOctober 16, 2025
- [H2] Twenty Years In Early Stage Biotech VC (Part 2): PeopleOctober 15, 2025
- [H2] Twenty Years In Early Stage Biotech VC (Part 1): ScienceOctober 14, 2025
- [H2] Biotech Wisdom Of The Crowds: Competition And CapitalismMay 28, 2025
- [H2] Biotech Venture Creation: The Benefits Of ScarcityApril 8, 2025
- [H2] Atlas XIV And Reflections On The VC Math ProblemDecember 5, 2024
- [H2] Atlas Venture 2024 Year In ReviewNovember 18, 2024
- [H2] Biotech Risk Cycles: Assets And PlatformsOctober 28, 2024
- [H2] A Molecular Biologist’s Advice For LifeJuly 1, 2024
- [H2] Mariana Oncology’s Radiopharm Platform Acquired By NovartisMay 6, 2024
- [H2] The Biotech Startup Contraction Continues… And That’s A Good ThingApril 26, 2024
- [H2] IFM’s Hat Trick and Reflections On Option-To-Buy M&AMarch 13, 2024
- [H2] Biotech Venture Ecosystem: Quick Health CheckJanuary 12, 2024
- [H2] Biotech Consolidation: Not Really HappeningNovember 30, 2023
- [H2] Atlas Venture 2023 Year In ReviewNovember 17, 2023
- [H2] Biotech Funding: Times Are Tough, Maybe For The BetterApril 14, 2023
- [H2] Science2Startup 2023: Innovation And EntrepreneurshipFebruary 28, 2023
- [H2] Takeda Acquires Nimbus’ Tyk2 Autoimmune ProgramDecember 13, 2022
- [H2] Atlas Venture 2022 Year In ReviewNovember 7, 2022
- [H2] Surprising Resilience Of Private VC-Backed Biotech MarketsJuly 6, 2022
- [H2] Responding To Tough Markets: Restructurings In BiotechApril 14, 2022
- [H2] Biotech’s January Chill: Big Drop In New StartupsApril 4, 2022
- [H2] In Defense Of Early Stage Biotech IPOsMarch 28, 2022
- [H2] Innovation Ecosystem: A Year Of Risk-Off CorrelationsMarch 21, 2022
- [H2] Biotech Bears: Jumping A Lower Bar Or A Higher One?March 17, 2022
- [H2] Getting Public Is Easy, Being Public Is HardNovember 18, 2021
- [H2] State of the Industry: 2021 Year In ReviewNovember 16, 2021
- [H2] Biotech’s Relevancy Challenge In An Expanding UniverseJune 1, 2021
- [H2] Five Macro Risks To Biotech Coming Out of WashingtonApril 22, 2021
- [H2] Biotech Funding Tops The Charts AgainApril 20, 2021
- [H2] Personal Reflection: Empathy In The WorkplaceMarch 16, 2021
- [H2] The Biotech Paradox of 2020: A Year In ReviewJanuary 4, 2021
- [H2] Biotech: The Featherweight Champion Of The MarketsNovember 20, 2020
- [H2] It’s Raining Biotech SPACs!October 15, 2020
- [H2] Evolution Of The Biotech IPO Markets From Busted To BoomingSeptember 21, 2020
- [H2] Kymera Debuts On The Public MarketsAugust 31, 2020
- [H2] The Record-Breaking Biotech Funding Tsunami Of 1H2020July 15, 2020
- [H2] Value Creation And Destruction: Dispersion of Performance In Biotech IPOsApril 17, 2020
- [H2] Booming VC-Backed Biopharma: Strong Market Despite PandemicApril 8, 2020
- [H2] Strategic Planning In Biotech During A Pandemic CrisisMarch 26, 2020
- [H3] search
- [H3] subscribe by email
- [H3] Twitter
- [H3] Recent Posts
- [H3] current comments
- [H3] topics
- [H3] monthly archive
Imagenes
Hemos encontrado 9 imágenes en esta web.
3 atributos alt están vacios o no existen. Agrega texto alternativo para que los motores de búsqueda puedan entender las imágenes.
Ratio Texto/HTML
Ratio : 17%
Bien, el ratio entre texto y código HTML de esta página es mayor que 15, pero menor que 25 por ciento.
Flash
Perfecto, no se ha detectado contenido Flash en la página.
Iframe
Genial, no se han detectado Iframes en la página.
Enlaces SEO
Reescritura URL
Bien. Tus enlaces parecen amigables
Guiones bajos en las URLs
Hemos detectado guiones bajos en tus URLs. Deberías usar guiones en su lugar para optimizar tu SEO.
Enlaces en página
Hemos encontrado un total de 289 enlaces incluyendo 0 enlace(s) a ficheros
| Ancla | Tipo | Jugo |
|---|---|---|
| Blog | Interna | Pasando Jugo |
| About Me | Interna | Pasando Jugo |
| From The Trenches | Interna | Pasando Jugo |
| Process-Driven Cadence: Biotech IPOs Demystified | Interna | Pasando Jugo |
| Capital markets | Interna | Pasando Jugo |
| Exits IPOs M&As | Interna | Pasando Jugo |
| - | Externo | Pasando Jugo |
| - | Externo | Pasando Jugo |
| - | Externo | Pasando Jugo |
| - | Externo | Pasando Jugo |
| - | Externo | Pasando Jugo |
| how fundamentally it changed the IPO process | Interna | Pasando Jugo |
| Comment | Interna | Pasando Jugo |
| Atlas Venture 2025 Year In Review | Interna | Pasando Jugo |
| Atlas Venture | Interna | Pasando Jugo |
| Biotech financing | Interna | Pasando Jugo |
| Drug discovery | Interna | Pasando Jugo |
| Pharma industry | Interna | Pasando Jugo |
| Pricing and Policy | Interna | Pasando Jugo |
| R&D Productivity | Interna | Pasando Jugo |
| Science & Medicine | Interna | Pasando Jugo |
| - | Externo | Pasando Jugo |
| - | Externo | Pasando Jugo |
| - | Externo | Pasando Jugo |
| - | Externo | Pasando Jugo |
| - | Externo | Pasando Jugo |
| 2024 | Interna | Pasando Jugo |
| 2023 | Interna | Pasando Jugo |
| 2022 | Interna | Pasando Jugo |
| 2021 | Interna | Pasando Jugo |
| 2020 | Interna | Pasando Jugo |
| 2019 | Interna | Pasando Jugo |
| 2018 | Interna | Pasando Jugo |
| Comment | Interna | Pasando Jugo |
| Twenty Years In Early Stage Biotech VC (Part 3): Business | Interna | Pasando Jugo |
| Twenty Years In Early Stage Biotech VC (Part 2): People | Interna | Pasando Jugo |
| Twenty Years In Early Stage Biotech VC (Part 1): Science | Interna | Pasando Jugo |
| Biotech Wisdom Of The Crowds: Competition And Capitalism | Interna | Pasando Jugo |
| Biotech Venture Creation: The Benefits Of Scarcity | Interna | Pasando Jugo |
| Atlas XIV And Reflections On The VC Math Problem | Interna | Pasando Jugo |
| Biotech Risk Cycles: Assets And Platforms | Interna | Pasando Jugo |
| A Molecular Biologist’s Advice For Life | Interna | Pasando Jugo |
| Mariana Oncology’s Radiopharm Platform Acquired By Novartis | Interna | Pasando Jugo |
| The Biotech Startup Contraction Continues… And That’s A Good Thing | Interna | Pasando Jugo |
| IFM’s Hat Trick and Reflections On Option-To-Buy M&A | Interna | Pasando Jugo |
| Biotech Venture Ecosystem: Quick Health Check | Interna | Pasando Jugo |
| Biotech Consolidation: Not Really Happening | Interna | Pasando Jugo |
| Biotech Funding: Times Are Tough, Maybe For The Better | Interna | Pasando Jugo |
| Science2Startup 2023: Innovation And Entrepreneurship | Interna | Pasando Jugo |
| Takeda Acquires Nimbus’ Tyk2 Autoimmune Program | Interna | Pasando Jugo |
| Surprising Resilience Of Private VC-Backed Biotech Markets | Interna | Pasando Jugo |
| Responding To Tough Markets: Restructurings In Biotech | Interna | Pasando Jugo |
| Biotech’s January Chill: Big Drop In New Startups | Interna | Pasando Jugo |
| In Defense Of Early Stage Biotech IPOs | Interna | Pasando Jugo |
| Innovation Ecosystem: A Year Of Risk-Off Correlations | Interna | Pasando Jugo |
| Biotech Bears: Jumping A Lower Bar Or A Higher One? | Interna | Pasando Jugo |
| Getting Public Is Easy, Being Public Is Hard | Interna | Pasando Jugo |
| Biotech’s Relevancy Challenge In An Expanding Universe | Interna | Pasando Jugo |
| Five Macro Risks To Biotech Coming Out of Washington | Interna | Pasando Jugo |
| Biotech Funding Tops The Charts Again | Interna | Pasando Jugo |
| Personal Reflection: Empathy In The Workplace | Interna | Pasando Jugo |
| Biotech: The Featherweight Champion Of The Markets | Interna | Pasando Jugo |
| It’s Raining Biotech SPACs! | Interna | Pasando Jugo |
| Kymera Debuts On The Public Markets | Interna | Pasando Jugo |
| The Record-Breaking Biotech Funding Tsunami Of 1H2020 | Interna | Pasando Jugo |
| Value Creation And Destruction: Dispersion of Performance In Biotech IPOs | Interna | Pasando Jugo |
| Booming VC-Backed Biopharma: Strong Market Despite Pandemic | Interna | Pasando Jugo |
| Strategic Planning In Biotech During A Pandemic Crisis | Interna | Pasando Jugo |
| Tweets by @LifeSciVC | Externo | Pasando Jugo |
| Balancing the Risks and Rewards of Drug Development in China: A Small Biotech CEO Perspective | Interna | Pasando Jugo |
| Ex-US Clinical Trials: Tribulations, Preparations, and Expectations | Interna | Pasando Jugo |
| Dual Wielding in I&I: A Pivotal Year Ahead | Interna | Pasando Jugo |
| Why Owning the Learning Loop Matters More Than Owning the Lab | Interna | Pasando Jugo |
| Two’s Company, Three’s Diversity | Interna | Pasando Jugo |
| Two’s Company, Three’s Diversity | Interna | Pasando Jugo |
| AliFarquhar | Externo | Pasando Jugo |
| Two’s Company, Three’s Diversity | Interna | Pasando Jugo |
| When Does Digital Health Become Just Healthcare? | Interna | Pasando Jugo |
| We Saw It Coming In Pharma: Now Gene Therapy Is Biotech 2.0 For Rare Diseases | Interna | Pasando Jugo |
| #RunningAtlas | Interna | Pasando Jugo |
| Adaptive Sports | Interna | Pasando Jugo |
| Bioentrepreneurship | Interna | Pasando Jugo |
| Biotech investment themes | Interna | Pasando Jugo |
| Biotech startup advice | Interna | Pasando Jugo |
| Boards and governance | Interna | Pasando Jugo |
| Boston Cluster | Interna | Pasando Jugo |
| Business Development | Interna | Pasando Jugo |
| Capital efficiency | Interna | Pasando Jugo |
| China | Interna | Pasando Jugo |
| Corporate Culture | Interna | Pasando Jugo |
| Diagnostics | Interna | Pasando Jugo |
| External R&D | Interna | Pasando Jugo |
| FDA | Interna | Pasando Jugo |
| From The Trenches | Interna | Pasando Jugo |
| Fundraising | Interna | Pasando Jugo |
| General Venture Capital | Interna | Pasando Jugo |
| Governance | Interna | Pasando Jugo |
| Leadership | Interna | Pasando Jugo |
| Marketing | Interna | Pasando Jugo |
| New business models | Interna | Pasando Jugo |
| Patients | Interna | Pasando Jugo |
| Personal | Interna | Pasando Jugo |
| Personalized Medicine | Interna | Pasando Jugo |
| Portfolio news | Interna | Pasando Jugo |
| Rare Diseases | Interna | Pasando Jugo |
| Strategy | Interna | Pasando Jugo |
| Talent | Interna | Pasando Jugo |
| The Human Element | Interna | Pasando Jugo |
| Translational research | Interna | Pasando Jugo |
| Uncategorized | Interna | Pasando Jugo |
| VC-backed Biotech Returns | Interna | Pasando Jugo |
| March 2026 | Interna | Pasando Jugo |
| February 2026 | Interna | Pasando Jugo |
| January 2026 | Interna | Pasando Jugo |
| December 2025 | Interna | Pasando Jugo |
| November 2025 | Interna | Pasando Jugo |
| October 2025 | Interna | Pasando Jugo |
| September 2025 | Interna | Pasando Jugo |
| August 2025 | Interna | Pasando Jugo |
| July 2025 | Interna | Pasando Jugo |
| June 2025 | Interna | Pasando Jugo |
| May 2025 | Interna | Pasando Jugo |
| April 2025 | Interna | Pasando Jugo |
| March 2025 | Interna | Pasando Jugo |
| February 2025 | Interna | Pasando Jugo |
| January 2025 | Interna | Pasando Jugo |
| December 2024 | Interna | Pasando Jugo |
| November 2024 | Interna | Pasando Jugo |
| October 2024 | Interna | Pasando Jugo |
| September 2024 | Interna | Pasando Jugo |
| August 2024 | Interna | Pasando Jugo |
| July 2024 | Interna | Pasando Jugo |
| June 2024 | Interna | Pasando Jugo |
| May 2024 | Interna | Pasando Jugo |
| April 2024 | Interna | Pasando Jugo |
| March 2024 | Interna | Pasando Jugo |
| February 2024 | Interna | Pasando Jugo |
| January 2024 | Interna | Pasando Jugo |
| November 2023 | Interna | Pasando Jugo |
| October 2023 | Interna | Pasando Jugo |
| September 2023 | Interna | Pasando Jugo |
| August 2023 | Interna | Pasando Jugo |
| July 2023 | Interna | Pasando Jugo |
| June 2023 | Interna | Pasando Jugo |
| May 2023 | Interna | Pasando Jugo |
| April 2023 | Interna | Pasando Jugo |
| March 2023 | Interna | Pasando Jugo |
| February 2023 | Interna | Pasando Jugo |
| January 2023 | Interna | Pasando Jugo |
| December 2022 | Interna | Pasando Jugo |
| November 2022 | Interna | Pasando Jugo |
| October 2022 | Interna | Pasando Jugo |
| September 2022 | Interna | Pasando Jugo |
| August 2022 | Interna | Pasando Jugo |
| July 2022 | Interna | Pasando Jugo |
| June 2022 | Interna | Pasando Jugo |
| May 2022 | Interna | Pasando Jugo |
| April 2022 | Interna | Pasando Jugo |
| March 2022 | Interna | Pasando Jugo |
| February 2022 | Interna | Pasando Jugo |
| January 2022 | Interna | Pasando Jugo |
| November 2021 | Interna | Pasando Jugo |
| October 2021 | Interna | Pasando Jugo |
| September 2021 | Interna | Pasando Jugo |
| August 2021 | Interna | Pasando Jugo |
| July 2021 | Interna | Pasando Jugo |
| June 2021 | Interna | Pasando Jugo |
| May 2021 | Interna | Pasando Jugo |
| April 2021 | Interna | Pasando Jugo |
| March 2021 | Interna | Pasando Jugo |
| January 2021 | Interna | Pasando Jugo |
| December 2020 | Interna | Pasando Jugo |
| November 2020 | Interna | Pasando Jugo |
| October 2020 | Interna | Pasando Jugo |
| September 2020 | Interna | Pasando Jugo |
| August 2020 | Interna | Pasando Jugo |
| July 2020 | Interna | Pasando Jugo |
| June 2020 | Interna | Pasando Jugo |
| May 2020 | Interna | Pasando Jugo |
| April 2020 | Interna | Pasando Jugo |
| March 2020 | Interna | Pasando Jugo |
| February 2020 | Interna | Pasando Jugo |
| January 2020 | Interna | Pasando Jugo |
| December 2019 | Interna | Pasando Jugo |
| November 2019 | Interna | Pasando Jugo |
| October 2019 | Interna | Pasando Jugo |
| September 2019 | Interna | Pasando Jugo |
| August 2019 | Interna | Pasando Jugo |
| July 2019 | Interna | Pasando Jugo |
| May 2019 | Interna | Pasando Jugo |
| April 2019 | Interna | Pasando Jugo |
| March 2019 | Interna | Pasando Jugo |
| February 2019 | Interna | Pasando Jugo |
| January 2019 | Interna | Pasando Jugo |
| December 2018 | Interna | Pasando Jugo |
| November 2018 | Interna | Pasando Jugo |
| October 2018 | Interna | Pasando Jugo |
| September 2018 | Interna | Pasando Jugo |
| August 2018 | Interna | Pasando Jugo |
| July 2018 | Interna | Pasando Jugo |
| June 2018 | Interna | Pasando Jugo |
| May 2018 | Interna | Pasando Jugo |
| April 2018 | Interna | Pasando Jugo |
| March 2018 | Interna | Pasando Jugo |
| February 2018 | Interna | Pasando Jugo |
| January 2018 | Interna | Pasando Jugo |
| December 2017 | Interna | Pasando Jugo |
| November 2017 | Interna | Pasando Jugo |
| October 2017 | Interna | Pasando Jugo |
| September 2017 | Interna | Pasando Jugo |
| August 2017 | Interna | Pasando Jugo |
| July 2017 | Interna | Pasando Jugo |
| June 2017 | Interna | Pasando Jugo |
| May 2017 | Interna | Pasando Jugo |
| April 2017 | Interna | Pasando Jugo |
| March 2017 | Interna | Pasando Jugo |
| February 2017 | Interna | Pasando Jugo |
| January 2017 | Interna | Pasando Jugo |
| December 2016 | Interna | Pasando Jugo |
| November 2016 | Interna | Pasando Jugo |
| October 2016 | Interna | Pasando Jugo |
| September 2016 | Interna | Pasando Jugo |
| August 2016 | Interna | Pasando Jugo |
| July 2016 | Interna | Pasando Jugo |
| June 2016 | Interna | Pasando Jugo |
| May 2016 | Interna | Pasando Jugo |
| April 2016 | Interna | Pasando Jugo |
| March 2016 | Interna | Pasando Jugo |
| February 2016 | Interna | Pasando Jugo |
| January 2016 | Interna | Pasando Jugo |
| December 2015 | Interna | Pasando Jugo |
| November 2015 | Interna | Pasando Jugo |
| October 2015 | Interna | Pasando Jugo |
| September 2015 | Interna | Pasando Jugo |
| August 2015 | Interna | Pasando Jugo |
| July 2015 | Interna | Pasando Jugo |
| June 2015 | Interna | Pasando Jugo |
| May 2015 | Interna | Pasando Jugo |
| April 2015 | Interna | Pasando Jugo |
| March 2015 | Interna | Pasando Jugo |
| February 2015 | Interna | Pasando Jugo |
| January 2015 | Interna | Pasando Jugo |
| December 2014 | Interna | Pasando Jugo |
| November 2014 | Interna | Pasando Jugo |
| October 2014 | Interna | Pasando Jugo |
| September 2014 | Interna | Pasando Jugo |
| August 2014 | Interna | Pasando Jugo |
| July 2014 | Interna | Pasando Jugo |
| June 2014 | Interna | Pasando Jugo |
| May 2014 | Interna | Pasando Jugo |
| April 2014 | Interna | Pasando Jugo |
| March 2014 | Interna | Pasando Jugo |
| February 2014 | Interna | Pasando Jugo |
| January 2014 | Interna | Pasando Jugo |
| December 2013 | Interna | Pasando Jugo |
| November 2013 | Interna | Pasando Jugo |
| October 2013 | Interna | Pasando Jugo |
| September 2013 | Interna | Pasando Jugo |
| August 2013 | Interna | Pasando Jugo |
| July 2013 | Interna | Pasando Jugo |
| June 2013 | Interna | Pasando Jugo |
| May 2013 | Interna | Pasando Jugo |
| April 2013 | Interna | Pasando Jugo |
| March 2013 | Interna | Pasando Jugo |
| February 2013 | Interna | Pasando Jugo |
| January 2013 | Interna | Pasando Jugo |
| December 2012 | Interna | Pasando Jugo |
| November 2012 | Interna | Pasando Jugo |
| October 2012 | Interna | Pasando Jugo |
| September 2012 | Interna | Pasando Jugo |
| August 2012 | Interna | Pasando Jugo |
| July 2012 | Interna | Pasando Jugo |
| June 2012 | Interna | Pasando Jugo |
| May 2012 | Interna | Pasando Jugo |
| April 2012 | Interna | Pasando Jugo |
| March 2012 | Interna | Pasando Jugo |
| February 2012 | Interna | Pasando Jugo |
| January 2012 | Interna | Pasando Jugo |
| December 2011 | Interna | Pasando Jugo |
| November 2011 | Interna | Pasando Jugo |
| October 2011 | Interna | Pasando Jugo |
| September 2011 | Interna | Pasando Jugo |
| August 2011 | Interna | Pasando Jugo |
| July 2011 | Interna | Pasando Jugo |
| June 2011 | Interna | Pasando Jugo |
| May 2011 | Interna | Pasando Jugo |
| April 2011 | Interna | Pasando Jugo |
| March 2011 | Interna | Pasando Jugo |
| Privacy Policy | Interna | Pasando Jugo |
Palabras Clave SEO
Nube de Palabras Clave
venture april leave biotech march january comment year ipo november
Consistencia de las Palabras Clave
| Palabra Clave (Keyword) | Contenido | Título | Palabras Claves (Keywords) | Descripción | Titulos |
|---|---|---|---|---|---|
| biotech | 42 |  |
 |
|
|
| ipo | 28 | |
|
|
|
| comment | 22 | |
|
|
|
| leave | 22 | |
|
|
|
| april | 21 | |
|
|
|
Usabilidad
Url
Dominio : lifescivc.com
Longitud : 13
Favicon
Genial, tu web tiene un favicon.
Imprimibilidad
No hemos encontrado una hoja de estilos CSS para impresión.
Idioma
Genial. Has declarado el idioma en.
Dublin Core
Esta página no usa Dublin Core.
Documento
Tipo de documento (Doctype)
HTML 5
Codificación
Perfecto. Has declarado como codificación UTF-8.
Validez W3C
Errores : 0
Avisos : 0
Privacidad de los Emails
Atención! Hemos encontrado por lo menos una dirección de correo electrónico en texto plano. Usa este protector antispam gratuito para ocultarla de los spammers.
HTML obsoleto
Genial, no hemos detectado ninguna etiqueta HTML obsoleta.
Consejos de Velocidad
|
Excelente, esta web no usa tablas. |
|
Muy mal, tu web está usando estilos embenidos (inline CSS). |
|
Muy mal, tu página web usa demasiados ficheros CSS (más de 4). |
|
Muy mal, tu sitio usa demasiados ficheros JavaScript (más de 6). |
|
Su sitio web se beneficia del tipo de compresión gzip. ¡Perfecto! |
Movil
Optimización Móvil
|
Icono para Apple |
|
Etiqueta Meta Viewport |
|
Contenido Flash |
Optimización
Mapa del sitio XML
¡Perfecto! Su sitio tiene un mapa del sitio en XML.
| https://lifescivc.com/sitemap_index.xml |
Robots.txt
https://lifescivc.com/robots.txt
¡Estupendo! Su sitio web tiene un archivo robots.txt.
Herramientas de Analítica
¡Perfecto! Su sitio web tiene una herramienta de análisis.
Google Analytics |
PageSpeed Insights
Dispositivo
Categorias
Free SEO Testing Tool
Free SEO Testing Tool es una herramienta seo gratuita que te ayuda a analizar tu web